Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOC2L mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NOC2L mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Estradiol results in increased expression of NOC2L mRNA | CTD | PMID:23019147 and PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NOC2L mRNA | CTD | PMID:22298810 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Fenretinide results in increased expression of NOC2L mRNA | CTD | PMID:28973697 | all-trans-retinoic acid | decreases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NOC2L mRNA | CTD | PMID:23724009 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of NOC2L mRNA | CTD | PMID:30779732 | aristolochic acid A | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of NOC2L mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | NOC2L (Homo sapiens) | 6480464 | Arsenic affects the methylation of NOC2L gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | NOC2L (Homo sapiens) | 6480464 | Arsenic affects the methylation of NOC2L gene | CTD | PMID:25304211 | benzatropine | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Benztropine results in increased expression of NOC2L protein | CTD | PMID:34122009 | benzo[a]pyrene | increases methylation | ISO | NOC2L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of NOC2L 3' UTR | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | NOC2L (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of NOC2L intron | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of NOC2L mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NOC2L mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol F | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | caffeine | decreases phosphorylation | ISO | NOC2L (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of NOC2L protein | CTD | PMID:35688186 | carbon nanotube | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NOC2L gene] | CTD | PMID:28238834 | chlorpyrifos | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | Chlorpyrifos affects the expression of NOC2L mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of NOC2L mRNA | CTD | PMID:28472532 | chrysene | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | chrysene results in increased expression of NOC2L mRNA | CTD | PMID:26377693 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOC2L mRNA | CTD | PMID:17602206 | clozapine | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Clozapine results in increased expression of NOC2L protein | CTD | PMID:34122009 | coumarin | affects phosphorylation | ISO | NOC2L (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of NOC2L protein | CTD | PMID:35688186 | dexamethasone | decreases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of NOC2L mRNA | CTD | PMID:12782123 | dexamethasone | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | dicrotophos | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | dicrotophos results in increased expression of NOC2L mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Noc2l (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC2L mRNA | CTD | PMID:30529165 | doxorubicin | decreases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NOC2L mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Noc2l (Mus musculus) | 6480464 | Ethanol affects the splicing of NOC2L mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of NOC2L mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of NOC2L mRNA | CTD | PMID:24793618 | FR900359 | affects phosphorylation | ISO | NOC2L (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of NOC2L protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of NOC2L mRNA | CTD | PMID:22061828 | indometacin | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of NOC2L protein | CTD | PMID:32959892 | methapyrilene | increases methylation | ISO | NOC2L (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of NOC2L intron | CTD | PMID:30157460 | methotrexate | decreases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of NOC2L mRNA | CTD | PMID:24449571 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOC2L mRNA | CTD | PMID:17602206 | paracetamol | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | Acetaminophen affects the expression of NOC2L mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NOC2L mRNA | CTD | PMID:33387578 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOC2L mRNA | CTD | PMID:32680482 | pentachlorophenol | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of NOC2L mRNA | CTD | PMID:23892564 | resveratrol | decreases expression | ISO | Noc2l (Mus musculus) | 6480464 | resveratrol results in decreased expression of NOC2L protein | CTD | PMID:25505154 | SB 431542 | multiple interactions | ISO | NOC2L (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOC2L protein | CTD | PMID:37664457 | silicon dioxide | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of NOC2L mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of NOC2L mRNA | CTD | PMID:34032870 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of NOC2L mRNA | CTD | PMID:25993096 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOC2L mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NOC2L mRNA | CTD | PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NOC2L mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of NOC2L mRNA | CTD | PMID:23411599 and PMID:34492290 | titanium dioxide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NOC2L mRNA | CTD | PMID:23131501 | trimellitic anhydride | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of NOC2L mRNA | CTD | PMID:19042947 | Triptolide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | triptolide results in increased expression of NOC2L mRNA | CTD | PMID:32835833 | valproic acid | increases methylation | ISO | NOC2L (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NOC2L gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | NOC2L (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NOC2L mRNA | CTD | PMID:23179753 | |